3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016" report to their offering.

3 Phosphoinositide Dependent Protein Kinase 1 3-phosphoinositide dependent protein kinase-1 (PDPK1) is a protein encoded by the PDPK1 gene. It plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB

AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. It activates PPARG transcriptional activity and promotes adipocyte differentiation. It controls proliferation, survival, and growth of developing pancreatic cells. It essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis.

3 Phosphoinositide Dependent Protein Kinase 1 pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. The molecules developed by Companies in Phase I and Preclinical stages are 1 and 4 respectively.

3 Phosphoinositide Dependent Protein Kinase 1 - Pipeline Review, H2 2016, outlays comprehensive information on the 3 Phosphoinositide Dependent Protein Kinase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in 3 Phosphoinositide Dependent Protein Kinase 1 targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Key Topics Covered:

  1. Introduction
  2. 3 Phosphoinositide Dependent Protein Kinase 1 Overview
  3. Therapeutics Development
  4. Pipeline Products for 3 Phosphoinositide Dependent Protein Kinase 1 - Overview
  5. Pipeline Products for 3 Phosphoinositide Dependent Protein Kinase 1 - Comparative Analysis
  6. 3 Phosphoinositide Dependent Protein Kinase 1 - Therapeutics under Development by Companies
  7. 3 Phosphoinositide Dependent Protein Kinase 1 - Therapeutics under Investigation by Universities/Institutes
  8. 3 Phosphoinositide Dependent Protein Kinase 1 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. 3 Phosphoinositide Dependent Protein Kinase 1 - Products under Development by Companies
  13. 3 Phosphoinositide Dependent Protein Kinase 1 - Products under Investigation by Universities/Institutes
  14. 3 Phosphoinositide Dependent Protein Kinase 1 - Companies Involved in Therapeutics Development
  • Arno Therapeutics, Inc.
  • Sunesis Pharmaceuticals, Inc.
  • Tolero Pharmaceuticals, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/6rqv2f/3

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes